LRI Investments LLC Boosts Stake in Intuitive Surgical, Inc. (NASDAQ:ISRG)

LRI Investments LLC boosted its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 5.3% during the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 1,379 shares of the medical equipment provider’s stock after purchasing an additional 70 shares during the period. LRI Investments LLC’s holdings in Intuitive Surgical were worth $742,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also recently modified their holdings of the company. State Street Corp increased its holdings in Intuitive Surgical by 1.4% during the third quarter. State Street Corp now owns 15,050,121 shares of the medical equipment provider’s stock valued at $7,393,673,000 after buying an additional 210,363 shares during the last quarter. FMR LLC lifted its holdings in Intuitive Surgical by 8.3% during the third quarter. FMR LLC now owns 10,971,085 shares of the medical equipment provider’s stock valued at $5,389,765,000 after purchasing an additional 838,793 shares in the last quarter. Fisher Asset Management LLC increased its stake in shares of Intuitive Surgical by 1.8% in the third quarter. Fisher Asset Management LLC now owns 4,782,381 shares of the medical equipment provider’s stock worth $2,349,441,000 after purchasing an additional 86,208 shares in the last quarter. Baillie Gifford & Co. lifted its stake in shares of Intuitive Surgical by 0.6% during the 3rd quarter. Baillie Gifford & Co. now owns 3,848,547 shares of the medical equipment provider’s stock valued at $1,890,676,000 after buying an additional 24,183 shares in the last quarter. Finally, Wellington Management Group LLP boosted its holdings in Intuitive Surgical by 1.7% in the 3rd quarter. Wellington Management Group LLP now owns 3,115,024 shares of the medical equipment provider’s stock worth $1,530,318,000 after buying an additional 53,383 shares during the period. 83.64% of the stock is currently owned by hedge funds and other institutional investors.

Insider Transactions at Intuitive Surgical

In related news, insider Mark Brosius sold 2,115 shares of the company’s stock in a transaction dated Thursday, September 12th. The stock was sold at an average price of $491.91, for a total value of $1,040,389.65. Following the completion of the transaction, the insider now owns 295 shares of the company’s stock, valued at approximately $145,113.45. This represents a 87.76 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, EVP Robert Desantis sold 376 shares of the stock in a transaction that occurred on Friday, November 29th. The shares were sold at an average price of $539.00, for a total value of $202,664.00. Following the transaction, the executive vice president now owns 5,506 shares in the company, valued at $2,967,734. This trade represents a 6.39 % decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 50,723 shares of company stock valued at $26,241,747. 0.80% of the stock is currently owned by corporate insiders.

Intuitive Surgical Price Performance

Shares of NASDAQ:ISRG opened at $550.41 on Monday. The business has a 50 day simple moving average of $516.21 and a two-hundred day simple moving average of $474.66. Intuitive Surgical, Inc. has a 1 year low of $307.72 and a 1 year high of $556.23. The firm has a market capitalization of $196.05 billion, a PE ratio of 88.49, a price-to-earnings-growth ratio of 5.41 and a beta of 1.38.

Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings results on Thursday, October 17th. The medical equipment provider reported $1.56 EPS for the quarter, topping the consensus estimate of $1.24 by $0.32. The company had revenue of $2.04 billion for the quarter, compared to the consensus estimate of $2.01 billion. Intuitive Surgical had a net margin of 28.51% and a return on equity of 13.41%. Equities research analysts expect that Intuitive Surgical, Inc. will post 5.45 EPS for the current fiscal year.

Analysts Set New Price Targets

Several analysts recently issued reports on the company. JPMorgan Chase & Co. increased their target price on Intuitive Surgical from $495.00 to $575.00 and gave the stock an “overweight” rating in a research report on Friday, October 11th. Robert W. Baird lifted their price target on shares of Intuitive Surgical from $503.00 to $565.00 and gave the company an “outperform” rating in a report on Thursday, October 17th. Erste Group Bank raised shares of Intuitive Surgical from a “hold” rating to a “buy” rating in a report on Tuesday, November 19th. Truist Financial lifted their target price on Intuitive Surgical from $520.00 to $570.00 and gave the stock a “buy” rating in a report on Monday, October 14th. Finally, The Goldman Sachs Group set a $604.00 target price on Intuitive Surgical in a research report on Friday, October 18th. One analyst has rated the stock with a sell rating, four have assigned a hold rating and fifteen have given a buy rating to the company’s stock. According to MarketBeat.com, Intuitive Surgical currently has an average rating of “Moderate Buy” and a consensus target price of $541.33.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.